The p53 paddy wagon: COP1, Pirh2, and MDM2 are found resisting apoptosis and growth arrest

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Biology & Therapy

• Publication date

  2004-05-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/cbt.3.8.1068PMID 15280670
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

  2004cited by this paper
• Yin Yang 1 is a negative regulator of p53.

  2004cited by this paper
• Mdm2 in the response to radiation.

  2004cited by this paper
• The ubiquitin ligase COP1 is a critical negative regulator of p53

  2004cited by this paper
• MDM2 and its splice variant messenger RNAs: expression in tumors and down-regulation using antisense oligonucleotides.

  2004cited by this paper
• p53 protein variants: structural and functional similarities with p63 and p73 isoforms

  2004cited by this paper
• Regulation of p53 by Mdm2: fate is in the numbers.

  2004cited by this paper
• Control of Human PIRH2 Protein Stability

  2004cited by this paper
• Overexpression of MDM2 oncoprotein correlates with possession of estrogen receptor alpha and lack of MDM2 mRNA splice variants in human breast cancer

  2004cited by this paper
• Mitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex

  2004cited by this paper
• Small-Molecule Antagonists of p53-MDM2 Binding: Research Tools and Potential Therapeutics

  2004cited by this paper
• Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis

  2004cited by this paper
• Human De-Etiolated-1 Regulates c-Jun by Assembling a CUL4A Ubiquitin Ligase

  2004cited by this paper
• Novel cancer therapy by reactivation of the p53 apoptosis pathway

  2003cited by this paper
• The p53-Mdm2 module and the ubiquitin system.

  2003cited by this paper
• Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.

  2003cited by this paper
• The codon 72 polymorphic variants of p53 have markedly different apoptotic potential

  2003cited by this paper
• Polyubiquitination of p53 by a Ubiquitin Ligase Activity of p300

  2003cited by this paper
• Parc: a cytoplasmic anchor for p53.

  2003cited by this paper
• Regulation of p53 responses by post-translational modifications

  2003cited by this paper
• p53-independent functions of MDM2.

  2003cited by this paper
• Restoring p53-Dependent Tumor Suppression

  2003cited by this paper
• Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation.

  2003cited by this paper
• PARC: A Potential Target for Cancer Therapy

  2003cited by this paper
• Characterization of Human Constitutive Photomorphogenesis Protein 1, a RING Finger Ubiquitin Ligase That Interacts with Jun Transcription Factors and Modulates Their Transcriptional Activity*

  2003cited by this paper
• Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription.

  2003cited by this paper
• p53 has a direct apoptogenic role at the mitochondria.

  2003cited by this paper
• Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2

  2003cited by this paper
• Intrasteric regulation of MDM2.

  2003cited by this paper
• ΔN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53

  2002cited by this paper
• Nuclear degradation of p53 occurs during down‐regulation of the p53 response after DNA damage

  2002cited by this paper
• Alternative and aberrant splicing of MDM2 mRNA in human cancer.

  2002cited by this paper
• An initial biochemical and cell biological characterization of the mammalian homologue of a central plant developmental switch, COP1

  2002cited by this paper
• Activation of the p53 tumor suppressor protein.

  2002cited by this paper
• Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity.

  2002cited by this paper
• p53 stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products

  2002cited by this paper
• Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53.

  2001cited by this paper
• Human mdm2 Mediates Multiple Mono-ubiquitination of p53 by a Mechanism Requiring Enzyme Isomerization*

  2001cited by this paper
• Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation

  2000cited by this paper
• MDM2-dependent ubiquitination of nuclear and cytoplasmic P53

  2000cited by this paper
• The MDM2 gene amplification database.

  1998cited by this paper
• JNK targets p53 ubiquitination and degradation in nonstressed cells.

  1998cited by this paper
• Characterization of a new intrabody directed against the N-terminal region of human p53

  1998cited by this paper
• Conformation-dependent phosphorylation of p53.

  1997cited by this paper
• Mdm‐2: “big brother” of p53

  1997cited by this paper
• A functional p53-responsive intronic promoter is contained within the human mdm2 gene.

  1995cited by this paper
• Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53

  1995cited by this paper
• Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53

  1995cited by this paper
• The p53-mdm-2 autoregulatory feedback loop.

  1993cited by this paper
• The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma.

  1993cited by this paper
• Amplification of a gene encoding a p53-associated protein in human sarcomas

  1992cited by this paper
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

  1992cited by this paper

• E3 Ubiquitin Ligases: Structures, Biological Functions, Diseases, and Therapy

  2025cites this paper
• The nucleocapsid protein facilitates p53 ubiquitination-dependent proteasomal degradation via recruiting host ubiquitin ligase COP1 in PEDV infection

  2024cites this paper
• Effect of COP1 in Promoting the Tumorigenesis of Gastric Cancer by Down-Regulation of CDH18 via PI3K/AKT Signal Pathway

  2023cites this paper
• p53, Pirh2, and L1CAM as Promising Prognostic Biomarkers of Endometrial Carcinoma: An Immunohistochemical and Genetic Study

  2022cites this paper
• TP53 in adult acute lymphoblastic leukemia

  2018cites this paper
• The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines

  2018cites this paper
• Constitutively Photomorphogenic 1 Reduces the Sensitivity of Chronic Lymphocytic Leukemia Cells to Fludarabine Through Promotion of Ubiquitin-Mediated P53 Degradation

  2018cites this paper
• The Measles Virus Expression Correlates with Classical Hodgkin Lymphoma and Other Malignancies. A Short Commentary

  2016cites this paper
• Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression

  2016cites this paper
• High expression of constitutive photomorphogenic 1 (COP1) is associated with poor prognosis in bladder cancer

  2016cites this paper
• Relevance of the Measles Virus Expression in Cancer - an Update

  2016cites this paper
• Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination.

  2015cites this paper
• Regulation of p53 oligomerization by Ras superfamily protein RBEL1A

  2015cites this paper
• POST-TRANSLATIONAL MODIFICATION OF ESTROGEN RECEPTOR ΑLPHA AND P 53 IN BREAST CANCER CELLS

  2015cites this paper
• Does the Measles Virus Contribute to Carcinogenesis? - A Review

  2014cites this paper
• Negative regulation of p53 by Ras superfamily protein RBEL1A

  2013cites this paper
• Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles.

  2011cites this paper
• Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy

  2011cites this paper
• Modelling the interaction between the p53 DNA‐binding domain and the p28 peptide fragment of Azurin

  2011cites this paper
• Drug discovery and mutant p53.

  2010cites this paper
• Porcine circovirus type 2 ORF 3 protein competes with P 53 in binding to Pirh 2 and mediates the deregulation of P 53 homeostasis

  2010cites this paper
• Substrate Phosphorylation and Feedback Regulation in JFK-promoted p53 Destabilization*

  2010cites this paper
• Identification of Pirh 2 D , an Additional Novel Isoform of Pirh 2 Ubiquitin Ligase

  2010cites this paper
• Modulating the p53 pathway.

  2010cites this paper
• Series : Thirty years of p 53 Drug discovery and mutant p 53

  2010cites this paper
• Porcine circovirus type 2 ORF3 protein competes with p53 in binding to Pirh2 and mediates the deregulation of p53 homeostasis.

  2010cites this paper
• COP1 contributes to UVB-induced signaling in human keratinocytes.

  2010cites this paper
• Identification of Pirh2D, an Additional Novel Isoform of Pirh2 Ubiquitin Ligase.

  2010cites this paper
• p53‐induced RING‐H2 protein, a novel marker for poor survival in hepatocellular carcinoma after hepatic resection

  2009cites this paper
• Identification and Characterization of Two Novel Isoforms of Pirh2 Ubiquitin Ligase That Negatively Regulate p53 Independent of RING Finger Domains*

  2009cites this paper
• Attenuation of porcine circovirus 2 in SPF piglets by abrogation of ORF3 function.

  2009cites this paper
• A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells

  2009influential citation
• The CXXC finger 5 protein is required for DNA damage-induced p53 activation

  2009cites this paper
• Energy Generating Pathways and the Tumor Suppressor p53

  2009cites this paper
• Alterations of tumour protein 53 (TP53) pathways in diffuse large B-cell lymphomas

  2009cites this paper
• Contribution of the DNA binding domain of p53 to regulation of its stability

  2008influential citation
• Liver‐specific expression of p53‐negative regulator mdm2 leads to growth retardation and fragile liver in zebrafish

  2008cites this paper
• A role for the cyclin box in the ubiquitin-mediated degradation of cyclin G1.

  2008cites this paper
• Phosphorylation of Pirh2 by Calmodulin‐dependent kinase II impairs its ability to ubiquitinate p53

  2007cites this paper
• Ubiquitination and Degradation of Mutant p53

  2007cites this paper
• The eIF2α Kinases PERK and PKR Activate Glycogen Synthase Kinase 3 to Promote the Proteasomal Degradation of p53*

  2007cites this paper
• Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers.

  2007cites this paper
• The ORF3 Protein of Porcine Circovirus Type 2 Interacts with Porcine Ubiquitin E3 Ligase Pirh2 and Facilitates p53 Expression in Viral Infection

  2007influential citation
• ARF-BP1 as a potential therapeutic target

  2006cites this paper
• On the mechanism of sequence-specific DNA-dependent acetylation of p53: the acetylation motif is exposed upon DNA binding.

  2006cites this paper
• Prospects for p 53-based cancer therapy

  2005cites this paper
• Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis

  2005cites this paper
• Prospects for p53-based cancer therapy.

  2005cites this paper
• P53 and prognosis: new insights and further complexity.

  2005cites this paper
• Prospects for p 53-based cancer therapy

  2005cites this paper
• Role of p53 in Double-Strand Break Repair

  2005cites this paper
• Description of the 290 probes used in the analysis

  year unknowncites this paper